Events

The 2022 Leadership and Faculty Development Program Conference and Minority Health Policy Annual Meeting will be held virtually, May 3rd through May 6th. Join us for rich discussions with clinicians and scholars about advancing health equity and addressing health disparities impacting the nation’s most vulnerable populations.

Abstract: The Institute for Clinical and Economic Review (ICER) fills a unique role in the U.S. health care landscape. As it passes its 15th year in operation, ICER’s impact has never been greater, yet significant obstacles still remain. What have been the lessons learned about conducting and communicating cost-effectiveness analyses for decision-makers in the U.S.? Steve Pearson, the Founder of […]

Crisis standards of care are guidelines that inform health care systems’ decisions around access to scarce medical resources. This includes access to medical beds, ventilators, medications, dialysis, extracorporeal membrane oxygenation, and other resources. The concept has received increased attention as the COVID-19 pandemic has challenged our health care systems. These guidelines pose concerns about the equitable provision of care. Chief […]

HBS Prof. Rem Koning will lead a discussion with alumnae Anula Jayasuriya (MBA 1993) and Halle Tecco (MBA 2011), who will share their experiences investing in women-led health care companies creating innovative products and services to address health needs most relevant to women. They will also weigh in on how we can better define "women's health” as a concept and […]

The federal 340B drug discount program provides certain providers with deep discounts on some outpatient drugs. Last year the 340B program saw substantial growth amidst uncertainty related to the use of contract pharmacies. The health care data and analytics firm, IQVIA, reported that in 2021, 340B program sales reached $93.6 billion and grew 15.9% year-on-year. However, last year more pharmaceutical […]

Join us for our next UMN MILI lab chat, where we talk to experts about key healthcare business topics every month. This May, we will talk to John O'Brien PharmD MPH, CEO of the National Pharmaceutical Council. This organization sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. As […]

Congresswoman Lauren Underwood, MS, MPH will deliver the virtual 2022 Charles C. Leighton, MD Memorial Lecture, featuring a conversation with Antonia Villarruel, PhD, RN, FAAN, the Margaret Bond Simon Dean of Penn Nursing.

Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. Featured speaker: Keith R. Dunleavy, MD, Founder and CEO of Inovalon. During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data […]

Continuing medical education and training in this era of disease-modifying treatments for the evolving SMA phenotype requires thoughtfulness for the most optimal outcomes.  With the implementation of the most current newborn screening guidelines, clinicians managing individuals with SMA require up-to-date knowledge on the treatment landscape, long-term outcomes, and clinical-decision making.  We intend to continue to enhance the knowledge and understanding […]

Missingness in Action is a consensus conference on the topic of absent and missing data and the future of AI in healthcare. Our goal is to bring together great minds to dive deeper into the critical and emerging issue of missing and non-representational data. We hope to scope the problem, identify solutions, and create a research agenda that might help […]